Project Grant HT94252410659
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02111, USA
Similar Awards
This $2,398,281 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant aims to increase access to evidence-based PTSD treatment for military service members and veterans through a study on Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary award recipient is the Palo Alto Veterans Institute for Research (PAVIR), a non-profit organization that specializes in medical...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This $5,024,305 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to augment Cognitive Processing Therapy (CPT) to prevent suicide risk among patients with PTSD. The grant was awarded to The Ohio State University on June 15, 2024 with a completion date of June 14, 2028. The project includes a sub-award to the University of Texas Health Science Center at San Antonio (UTHSCSA) to leverage the resources of the...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...
The Department of the Army Medical Command awarded a $2,430,944 project grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Texas Health Science Center of San Antonio. The grant aims to develop a web-based training for cognitive behavioral therapy for nightmares (CBT-N) to be delivered from September 1, 2021 through August 31, 2025. Several sub-awards were provided to partner organizations to support content development, video production,...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
This $4,208,345.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a hybrid 1 effectiveness-implementation trial of partner-assisted prolonged exposure for post-traumatic stress disorder (PTSD). The awardee, the Regents of the University of Minnesota, will leverage its expertise in medical research to conduct this investigation at the University of Minnesota in Minneapolis, MN. The award period runs from...
The federal Project Grant award of $5,954,349.00, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The primary awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans...